Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab to prevent periprosthetic bone loss after hip replacement in postmenopausal women
2011-000628-14Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hip osteoarthritis and osteoporosis comparing Denosumab (Prolia) with Placebo (2 arms). Primary endpoint: Periprosthetic bone mineral density change in proximal femur. Started Aug 2013; status: completed.
02
Drugs
denosumab
03
Conditions
hip osteoarthritisosteoporosis
Beyond the preview
Go deeper on 2011-000628-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000628-14.